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Objectives The present study investigated whether central blood pressure (BP) predicts cardiovascular (CV) events better
than brachial BP in a cohort of normotensive and untreated hypertensive elderly individuals.
Background Limited and conflicting data have been reported on the prognostic relevance of central BP compared with bra-
chial BP.
Methods Community-dwelling individuals 65 years of age, living in Dicomano, Italy, underwent an extensive clinical as-
sessment in 1995 including echocardiography and carotid ultrasonography and applanation tonometry. In 2003,
vital status and CV events were assessed, reviewing the electronic database of the Regional Ministry of Health.
Only normotensive (n  173) and untreated hypertensive subjects (95 diastolic and 130 isolated systolic) were
included in the present analysis.
Results During 8 years, 106 deaths, 45 of which were cardiovascular, and 122 CV events occurred. In univariate analy-
ses, both central and brachial systolic blood pressure (SBP) and pulse pressure (PP) predicted CV events (all
p  0.005); however, in multivariate analyses, adjusting for age and gender, higher carotid SBP and PP (hazard
ratios 1.19/10 and 1.23/10 mm Hg, respectively; both p  0.0001) but neither brachial SBP nor PP indepen-
dently predicted CV events. Similarly, higher carotid SBP but not brachial pressures independently predicted CV
mortality (hazard ratio 1.37/10 mm Hg; p  0.0001).
Conclusions Our prospective study in an unselected geriatric population demonstrates superior prognostic utility of central com-
pared with brachial BP. (J Am Coll Cardiol 2008;51:2432–9) © 2008 by the American College of Cardiology
Foundation
ublished by Elsevier Inc. doi:10.1016/j.jacc.2008.03.031p
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is life expectancy has increased in developed countries,
ardiovascular (CV) disease has become the most fre-
uent cause of mortality, morbidity, and disability in
lderly individuals. However, predictors of CV events in
lderly persons have not been evaluated extensively (1).
solated systolic hypertension (ISH) and associated wid-
ned pulse pressure (PP) occur more commonly in older
ndividuals. In an unselected elderly population, we
emonstrated that wider PP was associated with higher
eft ventricular (LV) mass, a greater number of carotid
rom the *Department of Critical Care Medicine and Surgery—Unit of Geriatric
ardiology, University of Firenze and Azienda Ospedaliero-Universitaria Careggi,
lorence, Italy; and the †Department of Medicine, Weill Medical College of Cornell
niversity, New York, New York.s
Manuscript received November 23, 2007; revised manuscript received March 5,
008; accepted March 11, 2008.laques, and increased vascular stiffness (2). In fact, ISH
s more strongly associated with cardiac and vascular
emodeling than is diastolic hypertension (3– 6), which,
n turn, might contribute to the greater risk of CV events
ssociated with ISH than with diastolic hypertension (7).
owever, whether blood pressure (BP) is a predictor in
lderly persons of CV events independent of CV target
rgan damage is unknown.
See page 2440
Increased arterial stiffness is one of the main determinants of
SH in elderly persons. However, arterial stiffening might be
ue to atherosclerosis and thereby be an indirect marker of an
ncreased risk of CV events (8), because central BP is more
trongly related to atherosclerosis than is brachial BP (2,9,10).
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June 24, 2008:2432–9 Carotid Pulse Pressure and Prognosishus, the present study investigated associations of central and
rachial BP and cardiac and vascular remodeling with CV
orbidity and mortality in an unselected elderly population to
etermine: 1) whether indexes of cardiac and vascular remod-
ling are more strongly associated with central than brachial
P, and 2) whether central BP predicts CV events better than
rachial BP in elderly subjects.
ethods
articipants. The study population was drawn from the
CARe Dicomano (Insufficienza Cardiaca negli Anziani
esidenti a Dicomano) study, a longitudinal epidemiologic
urvey of heart failure in a community-based sample of
lderly subjects from the small rural town of Dicomano,
ear Florence, Italy (11). In 1995, the ICARe Dicomano
tudy recruited the entire community-dwelling elderly (65
ears) population recorded in the City Registry Office of
icomano. The only initial exclusion criterion was living in
nursing home. The study was approved by an ad hoc ethics
ommittee. Individual informed consent was obtained, and
letter describing the study design was sent to primary
hysicians. Informed consent was obtained from the legal
aregiver, in the instance of cognitive dysfunction. For the
resent study, individuals taking antihypertensive drugs
ere excluded.
ata collection. Participants underwent clinical examina-
ion, 12-lead electrocardiogram, echocardiography, carotid
ltrasound, and carotid applanation tonometry. During the
linical examination, BP was measured with the participant
upine after a 10-min rest. Systolic blood pressure (SBP)
as defined as appearance of the first Korotkoff sound,
hereas diastolic blood pressure (DBP) was defined as
isappearance of the fifth Korotkoff sound. The second and
hird of 3 consecutive readings were averaged. The PP was
alculated as SBP  DBP. Mean BP was computed as
BP  (PP/3). Normotension was defined by clinical SBP
140 mm Hg and DBP 90 mm Hg; diastolic hyperten-
ion was defined by DBP 90 mm Hg regardless of SBP
alues; isolated systolic hypertension was defined as SBP
140 mm Hg and DBP 90 mm Hg.
chocardiography. From 2-dimensionally guided M-mode
chocardiograms, LV dimensions were measured by American
ociety of Echocardiography convention; LV mass was calcu-
ated by the adjusted American Society of Echocardiography
ethod (12) and indexed for body surface area. Left ventricular
ass/body surface area116 g/m2 in men and104 m/g2 in
omen was considered normal (13). Left ventricular fractional
hortening (FS) and stress-corrected midwall FS were calcu-
ated as described previously (14). Ejection fraction was calcu-
ated with bi-dimensional length-area method from apical
-chamber views.
arotid ultrasonography. As previously described (15,16),
-dimensionally guided M-mode tracings of the distal left
ommon carotid artery were obtained with simultaneous
ontralateral pressure waveform tracings (see following). aeasurements included intimal-
edial thickness (IMT) of the
ar wall at end-diastole and end-
iastolic and peak-systolic inter-
al carotid diameters; change in
iameter was defined as the per-
ent increase between diastolic
nd systolic internal carotid di-
meter (17). Relative wall thick-
ess of the common carotid
rtery and carotid wall cross-
ectional area (WCSA) was also
alculated (18,19). Both carotid
rteries were scanned to identify
he presence of atherosclerotic
laques defined as focally in-
reased IMT 50% of the sur-
ounding wall thickness; how-
ver, IMT was never measured at
he level of a discrete plaque.
laque score was defined as the
umber of left and right seg-
ents (common carotid, bulb,
nternal and external carotid ar-
eries, range 0 to 8) with discrete
laques (9).
arotid artery stiffness. Carotid pressure waveforms were
btained with a high-fidelity external pressure transducer
SPT-301B, Millar Instruments, Inc., Houston, Texas) ap-
lied to the skin overlying the common carotid artery (20) and
as calibrated with brachial mean and diastolic BP, mea-
ured at the end of the vascular ultrasound study with the
atient in a supine position. Carotid artery stiffness was
alculated by the pressure-independent stiffness index Beta,
hich takes into account the nonlinear relationship between
rterial pressure and diameter (21): Beta  ln(Ps/Pd)/([Ds 
d]/Dd), where Ps and Pd are the systolic and diastolic
arotid pressures and Ds and Dd are the systolic and
iastolic carotid diameters, respectively. The amplitude of
he reflected waves was expressed as a percentage of the PP,
s proposed by Murgo et al. (22), and as a percentage of the
BP; as previously demonstrated (2), this modified calcu-
ation of the AI reduces the potential attenuation of the
eflected wave contribution to the central pressure in sub-
ects with larger PP, as is commonly found in hypertensive
lderly subjects with ISH.
efinitions of events and follow-up. Events and vital
tatus were obtained from the electronic database of the
egional Ministry of Health, updated to December 2003.
ollow-up data were obtained for all subjects included in
his study. On the basis of nosologic coding, events and
ause of death were classified with the use of International
lassification of Diseases–9th Revision (ICD-9); ICD-9
odes from 390 to 459 were classified as CV. Nonfatal CV
vents were counted for all participants either alive or dead
Abbreviations
and Acronyms
AI  augmentation index
BP  blood pressure
CI  confidence interval
CV  cardiovascular
DBP  diastolic blood
pressure
FS  fractional shortening
HR  hazard ratio
IMT  intimal-medial
thickness
ISH  isolated systolic
hypertension
LV  left
ventricle/ventricular
MBP  mean blood
pressure
PP  pulse pressure
SBP  systolic blood
pressure
WCSA  wall cross-
sectional areat follow-up. If more than 1 CV event was recorded in the
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Carotid Pulse Pressure and Prognosis June 24, 2008:2432–9ame subject, only the first event was considered in the
nalysis. When counting for combined fatal and nonfatal
V events, if a subject had a nonfatal CV event and
ubsequently died of CV disease, only the nonfatal CV
vent was considered in the analysis (i.e., time to the first
onfatal event was used for time-dependent and survival
nalyses).
tatistical analysis. Data are expressed as mean  SD.
ifferences between 2 groups were tested by Student t
est for continuous variables and by chi-square statistics
or proportions. Bivariate relations were analyzed with
pearman correlation coefficient. Differences in the
trengths of association between central and peripheral
P and measures of CV remodeling were compared by
alculation of z statistics for comparison of correlations
ith a single sample. Univariate and multivariate survival
nalyses were performed with Cox regressions, and haz-
rd ratios (HRs) and corresponding 95% confidence
ntervals (CIs) were derived from these analyses. Analyses
ere performed separately to explore predictors of CV
ortality and combined nonfatal and fatal CV events. All
ignificant univariate predictors were included in the
ultivariate analysis. With a forward method (likelihood
atio method, with variables in by p  0.05 and out by
 0.1 to avoid biases due to colinearity), separate sets
f multivariate analyses were performed on the basis of
he aims of the study. To explore whether central
ressures predicted events more strongly than brachial
ressures, a Cox regression model was constructed for
ach carotid and brachial SBP and PP adjusting for age
Baseline Characteristics
Table 1 Baseline Characteristics
Overall
Age (yrs) 73 6
Male gender, n (%) 180 (45%)
BMI (kg/m2) 26.7 4.3
BSA (m2) 1.67 0.18
Heart rate (beats/min) 68 13
Brachial SBP (mm Hg) 145 19
Brachial PP (mm Hg) 61 16
Brachial MBP (mm Hg) 103 11
Glucose (mmol/l) 5.8 1.7
Creatinine (mol/l) 92 15
Total cholesterol (mmol/l) 5.88 1.12
HDL cholesterol (mg/dl) 1.48 0.45
LDL cholesterol (mg/dl) 3.70 1.06
Triglycerides (mmol/l) 0.09 0.05
Stroke, TIA, n (%) 20 (5%)
Peripheral vascular disease, n (%) 39 (10%)
Former or current smoker, n (%) 179 (45%)
Alcohol abuse, n (%) 87 (22%)
Coronary artery disease, n (%) 35 (9%)
Diabetes, n (%) 37 (9%)BMI  body mass index; BSA  body surface area; HDL  high-density lipop
PP  pulse pressure; SBP  systolic blood pressure; TIA  transient ischemnd gender. A two-tailed p  0.05 was considered
ignificant. Statistical software SPSS version 14.0 (SPSS
nc., Chicago, Illinois) was used for all statistical analysis.
esults
tudy population. Of the 899 residents in Dicomano 65
ears of age, 864 community-dwelling subjects were eligible
or the ICARe Dicomano study and 614 (71%) subjects
ompleted the assessment. Of the initial cohort, 216 sub-
ects were excluded for pharmacologic treatment of hyper-
ension. Of the remaining 398 subjects, 173 were normo-
ensive, 95 had diastolic hypertension, and 130 had ISH.
During an observational period of 2,818  716 days
range 460 to 3,172 days), 106 (27%) deaths were recorded,
5 of which were classified as of CV etiology (32 cardiac and
3 cerebrovascular diseases). One hundred thirteen partici-
ants suffered a nonfatal CV event, whereas 9 CV deaths
ccurred without a prior nonfatal CV event; thus, 122 fatal
nd nonfatal CV events (31% of the study sample) were
onsidered for subsequent analyses (80 cardiac and 42
erebrovascular diseases).
Baseline characteristics of the study cohort are shown in
ables 1 to 3. Participants who suffered CV events were
lder, more frequently male, and had higher SBP, PP, and
erum creatinine levels than those who did not suffer CV
vents; serum glucose levels and lipid profile were compa-
able between the 2 groups (Table 1). At baseline, comor-
idities (previous cerebrovascular accident, peripheral
ascular diseases, and coronary artery disease) were more
Incident Cardiovascular Events
No (n  276) p Value Yes (n  122)
72 6 0.0001 76 7
112 (41%) 0.005 68 (56%)
26.7 4.1 0.938 26.7 4.6
1.66 0.18 0.272 1.69 0.19
69 13 0.058 66 12
142 19 0.008 147 20
59 15 0.002 65 17
103 10 0.169 104 11
5.8 1.6 0.812 5.8 1.9
91 14 0.008 96 18
5.93 1.11 0.160 5.76 1.15
1.49 0.44 0.484 1.45 0.47
3.74 1.05 0.194 3.59 1.08
0.09 0.05 0.684 0.09 0.05
9 (3%) 0.015 11 (9%)
21 (8%) 0.026 18 (15%)
119 (43%) 0.245 60 (49%)
67 (24%) 0.083 20 (16%)
12 (4%) 0.0001 23 (19%)
21 (8%) 0.073 16 (13%)rotein; LDL  low-density lipoprotein; MBP  mean blood pressure;
ic attack.
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June 24, 2008:2432–9 Carotid Pulse Pressure and Prognosisrevalent in subjects who suffered CV events compared
ith those who did not; in addition, the former group had
arger LV and left atrial diameters, higher LV mass, and
ower LV systolic function. However, stress-corrected FS
nd diastolic function parameters did not differ significantly
etween the 2 groups (Table 2). At baseline, carotid
ressures, IMT, diameters, stiffness, and plaque prevalence
ere higher in participants who suffered subsequent CV
vents compared with those who did not (Table 3).
elation of brachial and carotid pressures to LV mass
nd carotid artery structure and function. In general, the
elation of brachial and central PPs to LV mass and carotid
Baseline Echocardiographic Findings
Table 2 Baseline Echocardiographic Finding
Overall
Left atrium (mm) 38.4 6.9
Aorta (mm) 32.7 4.3
IVSd (mm) 8.3 1.7
PWTd (mm) 7.8 1.3
LVIDd (mm) 51.9 6.1
LVIDs (mm) 32.3 6.6
FS (%) 38 8
Stress-corrected FS (%) 140 23
EF (%) 61 9
LV mass index (g/m2) 89 25
LV relative WT (%) 30 6
LV hypertrophy (LVMI) 60 (15%)
E wave (m/s) 0.60 0.17
A wave (m/s) 0.77 0.18
E/A 0.80 0.25
Relaxation time (ms) 98 19
Deceleration time (ms) 232 64
EF ejection fraction; FS fractional shortening; IVSd interventricu
internal diameter in diastole; LVIDs  left ventricular internal diame
posterior wall thickness in diastole; WT  wall thickness.
Baseline Carotid Artery Pressures, Structure, an
Table 3 Baseline Carotid Artery Pressures,
Overall
Systolic pressure (mm Hg) 134 20
PP (mm Hg) 58 18
IMT (mm) 0.84 0.16
Diastolic diameter (mm) 6.06 0.95
Systolic diameter (mm) 6.90 0.99
Strain (%) 14 5
Relative wall thickness 28 6
Wall cross-sectional area (mm2) 18.3 5.0
Plaque score 2 2
Plaque, n (%) 284 (71%)
Reflected wave (mm Hg) 17 11
AI (corrected for MBP) (%) 18 11
AI (corrected for PP) (%) 28 14
Peripheral amplification (mm Hg) 11 6
Stiffness index 4.7 2.5AI  augmentation index; BP  blood pressure; IMT  intimal-medial thicknrtery structure and function tended to be stronger than
orresponding systolic pressures (Table 4). Plaque score
xhibited a significantly stronger correlation with PP than
ith SBP for both brachial and carotid values. All indexes of
arotid stiffness (AI corrected by PP or by MBP and
tiffness index) exhibited stronger correlations with central
P than with brachial PP; of note, central PP had a stronger
orrelation with the modified AI corrected for MBP than
he AI corrected by PP (p  0.0001). Both AI corrected for
BP and the stiffness index correlated with WCSA (r 
.128, p  0.024 and r  0.239, p  0.0001, respectively)
nd carotid plaque score (r  0.169, p  0.003 and r 
Incident Cardiovascular Events
 276) p Value Yes (n  122)
 6.5 0.003 39.9 7.4
 4.4 0.152 33.1 4.2
 1.7 0.035 8.6 1.7
 1.2 0.002 8.1 1.4
 5.8 0.001 53.6 6.6
 5.9 0.001 34.4 7.6
 7 0.008 36 9
 22 0.878 140 26
 9 0.005 59 11
 22 0.0001 98 30
 6 0.428 31 7
(11%) 0.0001 29 (24%)
 0.17 0.872 0.60 0.18
 0.18 0.429 0.78 0.19
 0.24 0.786 0.79 0.29
 18 0.921 98 20
 58 0.186 239 75
um thickness in diastole; LV left ventricular; LVIDd left ventricular
ystole; LVMI  left ventricular mass index; PWTd  left ventricular
ffness
ture, and Stiffness
Incident Cardiovascular Events
No (n  276) p Value Yes (n  122)
131 18 0.0001 141 24
55 15 0.0001 65 20
0.83 0.15 0.046 0.87 0.18
5.92 0.84 0.0001 6.40 1.13
6.76 0.87 0.0001 7.23 1.17
14 5 0.054 13 4
29 6 0.148 27 6
17.7 4.4 0.001 19.9 6.0
2 2 0.0001 3 2
187 (68%) 0.003 97 (80%)
16 10 0.005 20 12
17 10 0.013 20 12
28 13 0.217 30 14
11 5 0.086 10 7
4.5 2.5 0.007 5.3 2.6s
No (n
37.7
32.4
8.2
7.6
51.2
31.4
39
141
62
85
30
31
0.60
0.76
0.80
98
229
lar septd Sti
Strucess; MBP  mean blood pressure; PP  pulse pressure.
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Carotid Pulse Pressure and Prognosis June 24, 2008:2432–9.224, p  0.0001, respectively), whereas the AI corrected
or PP did not relate to IMT, WCSA, or plaque score.
redictors of combined fatal and nonfatal CV events. In
nivariate analyses, older age, male gender, higher BP,
igher creatinine level, comorbidities, LV structure and
unction, and carotid artery abnormalities were predictors of
ombined fatal and nonfatal CV events (Table 5). When all
ignificant univariate predictors were included in a multi-
ariate Cox regression model, older age, male gender,
istory of coronary artery disease, increased carotid SBP,
nd higher carotid plaque score were independently associ-
ted with a higher incidence of CV events at follow-up.
elations of Brachial and Carotid Pressures to LV and Carotid Rem
Table 4 Relations of Brachial and Carotid Pressures to LV and
Brachial SBP
r p Value r
LV mass/body surface area (g/m2) 0.241 0.0001 0.269
Wall cross-sectional area (mm2) 0.190 0.001 0.227
Plaque score 0.151 0.008 0.229*
IMT (mm) 0.086 0.127 0.128
AI corrected by PP 0.189 0.001 0.174
AI corrected by MBP 0.334 0.0001 0.402*
Stiffness index 0.335 0.0001 0.386*
orrelations compared by Z statistics: brachial SBP versus brachial PP: *p  0.005; carotid SBP
p  0.0001; brachial PP versus carotid PP: p  0.005; #p  0.0001; **p  0.05.
LV  left ventricular; SBP  systolic blood pressure; other abbreviations as in Table 3.
Predictors of Cardiovascular Events
Table 5 Predictors of Cardiovascular Events
Univariate HR
(95% CI)
Age (yrs) 1.09 (1.06–1.12)
Male gender 1.69 (1.18–2.41)
Brachial SBP (10 mm Hg) 1.14 (1.04–1.25)
Brachial PP (10 mm Hg) 1.23 (1.11–1.38)
Creatinine (mol/l) 1.02 (1.01–1.03)
Previous stroke/TIA (yes) 2.43 (1.31–4.52)
Known PVD (yes) 1.97 (1.19–3.25)
CAD (yes) 3.44 (2.18–5.44)
Diabetes (yes) 1.76 (1.04–2.98)
Left atrium (mm) 1.04 (1.02–1.07)
FS (%) 0.96 (0.94–0.99)
EF (%) 0.97 (0.96–0.99)
LV mass index (g/m2) 1.02 (1.01–1.02)
LV hypertrophy (LVMI) 2.33 (1.52–3.59)
Carotid SBP (10 mm Hg) 1.28 (1.17–1.41)
Carotid PP (10 mm Hg) 1.34 (1.21–1.48)
IMT (mm) 3.65 (1.17–11.36
Wall cross-sectional area (mm2) 1.08 (1.04–1.12)
Plaque score 1.27 (1.17–1.38)
Plaque (Yes) 2.07 (1.28–3.36)
Reflected wave (mm Hg) 1.03 (1.01–1.05)
AI corrected for MBP (%) 1.03 (1.01–1.05)
Peripheral amplification (mm Hg) 0.96 (0.93–0.99)
Stiffness index 1.11 (1.04–1.17)
*A forward method was used on the basis of likelihood ratio, with var
AI  augmentation index; CAD  coronary artery disease; CI  conleft ventricular mass/body surface area; MBPmean blood pressure; PP pu
pressure; TIA  transient ischemic attack; other abbreviations as in Table 2.To analyze the relation of brachial and carotid SBP and
P to CV events without adjustment for the presence of
oronary and carotid atherosclerosis, separate models were
onstructed, including age, gender, and each independent
ressure (Table 6). Neither brachial pressure entered the
odels, whereas both carotid SBP and PP were significantly
elated to outcome. Moreover, when both brachial and
arotid SBP or brachial and carotid PP were inserted in a
ultivariate model with age and gender, only central pres-
ures remained in the models (p  0.0001 for carotid SBP
nd carotid PP), whereas brachial pressures did not enter
he models.
ng
tid Remodeling
ial PP Carotid SBP Carotid PP
p Value r p Value r p Value
0.0001 0.243 0.0001 0.276 0.0001
0.0001 0.221 0.0001 0.266 0.0001
0.0001 0.192 0.001 0.306† 0.0001
0.023 0.110 0.052 0.161 0.004
0.002 0.355‡ 0.0001 0.301§ 0.0001
0.0001 0.546¶ 0.0001 0.647†# 0.0001
0.0001 0.348 0.0001 0.500† 0.0001
arotid PP: §p  0.05; †p  0.0001; brachial SBP versus carotid SBP: ‡p  0.001;
p Value
Multivariate* HR
(95% CI) p Value
0.0001 1.08 (1.03–1.12) 0.0001
0.004 1.71 (1.04–2.83) 0.035
0.004
0.0001
0.001
0.005
0.008
0.0001 2.99 (1.65–5.40) 0.0001
0.036
0.002
0.002
0.001
0.0001
0.0001
0.0001 1.14 (1.02–1.28) 0.026
0.0001
0.025
0.0001
0.0001 1.14 (1.01–1.28) 0.028
0.003
0.001
0.003
0.020
0.001
ntered for p  0.05 and excluded for p  0.1.
interval; HR  hazard ratio; IMT  intimal-medial thickness; LVMI odeli
Caro
Brach
*
versus c)
iables e
fidencelse pressure; PVD peripheral vascular disease; SBP systolic blood
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June 24, 2008:2432–9 Carotid Pulse Pressure and Prognosisredictors of CV mortality. With the analysis restricted to
atal CV events, age (HR 1.23/year; 95% CI 1.14 to 1.34;
 0.001), male gender (HR 8.21; 95% CI 2.59 to 26.00;
 0.001), history of coronary artery disease (HR 7.41;
5% CI 2.44 to 22.50; p  0.001), and carotid SBP (HR
.33/10 mm Hg; 95% CI 1.03 to 1.72; p  0.029) were
ndependent predictors of CV mortality. Neither carotid PP
or brachial systolic and PPs were independently related to
he small number of fatal CV events.
iscussion
n a cohort of unselected community-dwelling normoten-
ive and untreated hypertensive elderly individuals, those
ho suffered incident CV events had a significant disease
urden at baseline, including LV structural and functional
bnormalities, carotid atherosclerosis, and more impaired
enal function. However, in a relatively short observational
eriod as in our study, age, male gender, previous coronary
rtery disease, carotid SBP (but not brachial), and carotid
therosclerosis were strong independent predictors of CV
vents. Moreover, central pressures were more strongly
ssociated with cardiac and vascular remodeling than were
rachial pressures.
entral versus brachial BP and vascular remodeling. Re-
ently, Roman et al. (9) analyzed the relation of brachial and
entral pressures to carotid hypertrophy and extent of
therosclerosis in a large cohort of American Indians
Strong Heart Study). The correlation coefficients re-
orted by Roman et al. were similar to those in the present
tudy. However, correlation coefficients between IMT and
rachial and central PP did not reach statistical significance
n the present study, likely owing to the smaller sample size.
oreover, our subjects were older than the subjects enrolled
n the Strong Heart Study, and therefore a smaller periph-
ral amplification of central PP can be expected in our
ohort with a consequent reduced difference in the correla-
ion coefficients between IMT and brachial and central PP.
n fact, in a group of relatively young adults, Boutouyrie et
l. (23) found that brachial over carotid PP ratio was
ttenuated by aging and that central but not brachial PP was
elated to carotid internal diameter. The greater impact of
entral BP compared with brachial BP in arterial remodel-
ng was also reported in 114 men with angiographically
ocumented coronary artery disease; in fact, Waddel et al.
ndependent Predictors of Cardiovascular Events
Table 6 Independent Predictors of Cardiovascular Events
HR (95% CI) p Value HR (95% CI)
Age (yrs) 1.09 (1.07–1.12) 0.0001 1.09 (1.07–1.12
Male gender 1.84 (1.29–1.64) 0.001 1.84 (1.29–1.64
Brachial SBP (/10 mm Hg) 0.119
Brachial PP (/10 mm Hg)
Carotid SBP (/10 mm Hg)
Carotid PP (/10 mm Hg)
bbreviations as in Table 5.24) demonstrated that the severity of coronary disease was nndependently related to carotid SBP (r  0.47, p  0.001)
nd carotid PP (r  0.45, p  0.001) but not to brachial
ressures. In our cohort of elderly subjects, the arterial
tiffness index and AI exhibited significant correlations with
CSA and plaque score but not with IMT; this difference
an be explained by the observations that AI plateaus at the
ge of 60 years or might even decrease after the age of 60
ears (25,26).
entral versus brachial BP and CV events. Our study
emonstrated that carotid atherosclerosis and carotid SBP
ere predictors of CV events independent of age. In the
ardiovascular Health Study, subclinical carotid stenosis
which might underestimate atherosclerotic burden) was an
ndependent predictor of events (27). However, we further
emonstrated that incident CV events were more likely in
ree-living elderly subjects with a higher carotid plaque
core, a measure of disease burden. Therefore, therapy
argeting central BP and atherosclerosis (or other target
rgan damage) might impact CV event rates in older
opulations. In fact, in hypertensive patients from the LIFE
Losartan Intervention For Endpoint Reduction in Hyper-
ension) study, echocardiographic and electrocardiographic
bnormalities identified higher CV risk independent of
rachial BP reduction (28,29) and a significant impact of
spirin use on CV combined end point reduction (30)
ndependent of BP. Recently, data from the Strong Heart
tudy revealed similar strengths of age, male gender, and
arotid pressure in predicting CV outcome as in our study
9). In the Strong Heart Study, arterial stiffness was also
elated to CV outcome but did not emerge as an
ndependent predictor in the present study. This differ-
nce can be partially explained by differences in age
ranging from 18 to 88 years in the Strong Heart Study
nd from 65 to 94 years in the present analysis), because
tudies have reported that carotid stiffness, expressed as
I, increases with age in younger individuals (50 years),
hereas this relation disappears over age 50 years (26,31).
In our study population, LV structure and function were
ot independently related to CV events, and no significant
elation was found between LV ejection fraction and carotid
tiffness expressed as AI. Our findings are at variance with
hose reported by the Cardiovascular Health Study (32,33).
owever, in the Cardiovascular Health Study, the study
ample was larger, the observation time was longer, and the
Value HR (95% CI) p Value HR (95% CI) p Value
0.0001 1.10 (1.06–1.13) 0.0001 1.09 (1.06–1.13) 0.0001
0.001 1.92 (1.29–2.87) 0.001 1.97 (1.32–2.94) 0.001
0.063
1.19 (1.08–1.31) 0.0001
1.23 (1.10–1.37) 0.0001p
) 
)umber of events was greater. Moreover, in the Cardiovas-
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Carotid Pulse Pressure and Prognosis June 24, 2008:2432–9ular Health Study, LV functional parameters predicted
ew-onset congestive heart failure specifically, whereas we
valuated total fatal and nonfatal CV events. Our fatal CV
vents comprised mostly fatal acute coronary syndromes and
trokes (33% and 29%, respectively), and nonfatal events
ncluded mostly strokes or transient ischemic attacks and
cute coronary syndromes (34% and 24%, respectively),
hich might explain why indicators of atherosclerosis were
ore powerful predictors of CV rather than LV structural
nd functional abnormalities in our study.
Whether central BP is related to CV events more strongly
han brachial BP is debated (8,9,23,24,34–36). In the
AFE (Conduit Artery Function Evaluation) study, central
P was associated with clinical outcomes more strongly
han brachial PP (37). In contrast, Dart et al. (8) found a
reater prognostic impact of brachial than central PP. In a
opulation of patients who underwent coronary angiography
or established coronary artery disease, Chirinos et al. (38)
ound that central but not brachial PP was an independent
redictor of all-cause death, whereas the association of
ncreased central PP with incident CV events was borderline
p  0.057). In our study, we separately and specifically
valuated whether carotid PP predicted higher CV morbid-
ty and mortality more strongly than brachial PP. We found
hat central PP predicted incident CV events, whereas
rachial PP did not, independent of age and gender,
imilar to the study of Safar et al. (36) in patients with
nd-stage renal disease. Our results in an elderly population
rovide additional support to the recent Strong Heart Study
ndings (9) that increased central PP is associated with
reater LV and vascular remodeling as well as carotid
therosclerosis. In fact, subjects with increased PP have a
igher LV mass/body surface area and carotid atheroscle-
osis, and these abnormalities lead to an increased risk of
V events. In a previous study in a less elderly population,
igher brachial PP, indicative of increased arterial stiffness,
as found to be associated with higher CV mortality
ndependent of LV hypertrophy (39). In the present study,
e demonstrated that central BP, more than brachial BP,
redicted CV events, independent of carotid atherosclerosis.
tudy limitations. The hypertensive subjects included in
he present analysis were untreated at the time of enrollment
n the ICARe Dicomano study (1995), but no data are
vailable regarding antihypertensive treatment initiated dur-
ng follow-up. However, as previously demonstrated in a
ifferent subset of the ICARe Dicomano study, treated
ypertensive subjects with optimal BP control (brachial BP
140/90 mm Hg) had higher carotid PP than in normo-
ensive subjects (62  20 mm Hg vs. 50  14 mm Hg, p 
.004), despite normalized brachial PP (52  9 mm Hg vs.
8  mm Hg, p  NS). Thus, the association between
arotid PP and adverse outcome might be less affected by
he impact of antihypertensive treatments. A further limi-
ation of our study is that the prognostic importance of
ardiac and vascular remodeling was not a primary outcome
f the ICARe Dicomano study; thus, the sample size mighte too limited to avoid type 2 errors. However, this study
as the advantage of analyzing an unselected population of
lderly subjects of an entire town. Finally, both fatal and
onfatal events were classified as CV or non-CV on the
asis of the data recorded in the electronic database of the
egional Ministry of Health without an independent review
f medical records; thus, we cannot exclude that some event
ould be erroneously attributed to the wrong cause.
onclusions
ur prospective study in an unselected geriatric population
f normotensive and untreated hypertensive subjects dem-
nstrated that CV disease burden predicts CV events
ndependent of age and BP. Moreover, we demonstrated the
uperior prognostic importance of carotid BP over brachial
P, indicating that central BP should be taken into account
n the evaluation of the impact of therapeutic strategies on
utcomes.
eprint requests and correspondence: Dr. Riccardo Pini, Unit of
eriatric Cardiology, Via delle Oblate, 4, 50141 Florence, Italy.
-mail: rpini@unifi.it.
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